Determination of L-756 423, a novel HIV protease inhibitor, in human plasma and urine using high-performance liquid chromatography with fluorescence detection-Reference-Cited by-同舟云学术

Determination of L-756 423, a novel HIV protease inhibitor, in human plasma and urine using high-performance liquid chromatography with fluorescence detection

Published:1999-09 Issue:2 Volume:732 Page:425-435
ISSN:0378-4347
Container-title:Journal of Chromatography B: Biomedical Sciences and Applications
language:en
Short-container-title:Journal of Chromatography B: Biomedical Sciences and Applications

Author:

Rose Mark J,Merschman Sheila A,Woolf Eric J,Matuszewski Bogdan K

Publisher

Elsevier BV

Subject

General Chemistry

Reference20 articles.

1. Active human immunodeficiency virus protease is required for viral infectivity.

2. HIV proteinase as a target for drug action

3. MiniReview: Antiviral Targets Series, Number 1

4. L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

5. L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in urine bioanalytical assays: overcoming nonspecific binding;Bioanalysis;2010-09

2. Stabilization and determination of a PPAR agonist in human urine using automated 96-well liquid–liquid extraction and liquid chromatography/tandem mass spectrometry;Journal of Chromatography B;2006-10-02

3. Chapter 11 Solid-phase extraction: High throughput techniques;High Throughput Bioanalytical Sample Preparation - Methods and Automation Strategies;2003

4. Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS;Journal of Pharmaceutical and Biomedical Analysis;2002-10

5. Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection;Journal of Pharmaceutical and Biomedical Analysis;2002-06